PFIZER LTD Valuation
PFIZER · Healthcare · Current price ₹4,663.8
Is PFIZER LTD undervalued?
DocStoX estimates the fair value of PFIZER LTD at ₹3,003 per share, versus the current market price of ₹4,664. That puts the stock about -35.6% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹1,134), Relative P/E (₹4,788), Graham floor (₹1,807), Analyst target (₹6,369). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹1,134 (bear) to ₹3,003 (base) to ₹6,369 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
PFIZER LTD trades at a P/E of 29.5x and a P/B of 5.2x, with a dividend yield of 1.6%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on PFIZER LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.